Thomas Unterkircher, PhD Octapharma

Dr. Thomas Unterkircher acts as GLP study director at Octapharma’s Virus and Prion Validation department. Thomas joined the department in 2017 as a scientist. In his current role, he supervises virus validation studies for plasma-derived medicinal products. Furthermore, he is the responsible project leader for gene-technological matters and a subject matter expert for the Plasma Master File. He oversees assay development (NAT and infectivity-based methods) and is responsible for virus and prion-related matters concerning selected Octapharma products. After Thomas’ master’s degree in molecular biology at the University of Innsbruck, Austria, he worked in brain cancer research receiving a PhD in molecular medicine from the University of Ulm, Germany, and a postdoc fellowship from the University Hospital of Freiburg, Germany.